Ad is loading...
MENU
PTCT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
PTC Therapeutics (PTCT) Ownership - Who owns PTC Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
100 Corporate Court
Phone
+1 908 222-7000
Employees
1058
Web
https://www.ptcbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.03B
P/E Ratio
N/A
Total Cash
1.09B
Projected Growth
N/A
Total Debt
395.5M
Revenue
900.45M
Risk (Beta)
0.54
Dividend Yield
N/A
Total Cash/Share
14.18
Total Debt/Equity
0.01
Revenue/Share
11.79 USD as % of share price
Fundamentals
PTCT
Capitalization
3.03B
P/E Ratio
N/A
Risk (Beta)
0.54
Dividend Yield
N/A
Total Cash
1.09B
Total Cash/Share
14.18
Total Debt
396M
Total Debt/Equity
0.01
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
11.79%
Revenue
900M
ROE
N/A
Book Value
-980.18M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-6.31
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
76K
Current Ratio
2.23
Current Revenue Per Employee
187642.22
Dividends Per Share - Security
N/A
EBITDA
-132.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.68
Revenue To Assets
-29.47
Shares Held By Institutions
5.37B
Shares Outstanding - Current
77.1M
Total Liabilities
2.9B
Total Volume MTD
N/A
Value
-1
Gain YTD
42.344
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Corporate Court
Phone
+1 908 222-7000
Employees
1058
Web
https://www.ptcbio.com